15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2B | $609467 | 0.0% | 0.0% | — | $4.3B | $27M |
| 2024 | $1.1B | $417804 | 0.0% | 0.0% | — | $4.8B | $518M |
| 2023 | $950M | $248796 | 0.0% | 0.0% | — | $5.1B | $443M |
| 2022 | $878M | $438841 | 0.0% | 0.0% | — | $5.3B | $297M |
| 2021 | $1.1B | $428302 | 0.0% | 0.0% | — | $5.3B | $21M |
| 2020 | $892M | — | 0.0% | 0.0% | — | $5.2B | $164M |
| 2019 | $929M | — | 0.0% | 59.4% | — | $5.1B | $24M |
| 2018 | $882M | — | 0.0% | 56.4% | — | $4.5B | $10M |
| 2017 | $908M | — | 0.0% | 34.7% | — | $4.6B | $86M |
| 2016 | $901M | — | 0.0% | 62.2% | — | $4.4B | $94M |
| 2014 | — | $221M | — | — | — | $2.4B | $4M |
| 2013 | — | $173M | — | — | — | $2.0B | $3M |
| 2012 | — | $121M | — | — | — | $1.8B | $2M |
| 2011 | — | $53M | — | — | — | $1.6B | $351000 |
| 2010 | — | $58M | — | — | — | $1.2B | $7M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $7M | $151M | 0.0% | 0.0% | — | — | $26M |
| Dec '25 | — | $165M | — | — | — | $4.3B | $27M |
| Sep '25 | — | $180M | — | — | — | $5.0B | $737M |
| Jun '25 | — | $137M | — | — | — | $5.0B | $734M |
| Mar '25 | — | $109M | — | — | — | $4.4B | $368M |
| Dec '24 | — | $113M | — | — | — | $4.8B | $518M |
| Sep '24 | — | $112M | — | — | — | $4.9B | $342M |
| Jun '24 | — | $114M | — | — | — | $4.7B | $35M |
| Mar '24 | — | $67M | — | — | — | $5.0B | $362M |
| Sep '15 | — | $79M | — | — | — | $4.2B | $15M |
| Jun '15 | — | $41M | — | — | — | $3.4B | $25M |
| Mar '15 | — | $43M | — | — | — | $2.6B | $700M |
| Dec '14 | — | $57M | — | — | — | $2.4B | $4M |
| Sep '14 | — | $62M | — | — | — | $2.3B | $452000 |
| Jul '14 | — | $47M | — | — | — | — | — |
| Jun '14 | — | $47M | — | — | — | $2.4B | $29M |
| Mar '14 | — | $56M | — | — | — | $2.1B | $20M |
| Dec '13 | — | $47M | — | — | — | $2.0B | $3M |
| Sep '13 | — | $38M | — | — | — | $1.7B | $68M |
| Jun '13 | — | $49M | — | — | — | $1.7B | $7M |
How the market has priced OHI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Omega Healthcare Investors Inc's revenue has grown 5.9% per year, and net income grown 9.2% per year. These are computed facts, not advice.
As of FY2025, Omega Healthcare Investors Inc reported $4.3B of total debt against $27M of cash.
In FY2025, gross margin was —, operating margin —, and net margin 0.1%.
As of Jun '26, Omega Healthcare Investors Inc traded at a price-to-earnings ratio of about 23266.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.